Quality Control Reagents I - IV at Tempus

Durham, North Carolina, United States

Tempus Logo
Not SpecifiedCompensation
Entry Level & New Grad, Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Precision MedicineIndustries

Requirements

  • Highly organized and systematic, superb attention to detail and ability to complete tasks with a high degree of accuracy
  • Proven ability to learn new skills quickly and adapt to new processes smoothly
  • BS in medical technology, clinical laboratory science, chemical, physical or biological science
  • Prefer 1 year previous experience in a molecular lab or with laboratory liquid handlers
  • Moderate experience with Microsoft Excel and/or Google Sheets
  • Previous experience in a clinical lab regulated by CAP/CLIA/NYS/ISO is highly desirable
  • Good time management skills
  • Excellent communication skills

Responsibilities

  • Work within a cutting-edge genomics workflow to provide quality control support in a high-volume clinical molecular laboratory
  • Test and document new lots of reagents for clinical lab team processing and label reagents approved for use
  • Maintain reagent qualification records and manage quality control of reagent inventory
  • Document all results and findings in order to satisfy CLIA/CAP/NYS-DOH/ISO compliance
  • Collect and help analyze metrics
  • Investigate reagent related issues and help facilitate and implement corrective and preventative actions
  • Interact with lab management and personnel to provide training, troubleshoot issues, and prioritize QC tasks
  • Report significant findings/deviations and system deficiencies to lab management, as appropriate
  • Update SOPs and records within the document control system, including creation/revision/review of internal SOPs and other quality documentation
  • Complete Performance Qualifications (PQs) and support the Lab QC team with equipment and documentation tasks as needed
  • Monitor and respond to laboratory temperature excursions

Skills

Quality Control
Reagent Testing
Genomics Workflow
CLIA Compliance
CAP Compliance
ISO Compliance
SOP Management
Document Control
Inventory Management
Molecular Lab
Laboratory Liquid Handlers
Performance Qualifications
Temperature Monitoring
Metrics Analysis
Troubleshooting

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters
2015Year Founded
$894.9MTotal Funding
IPOCompany Stage
AI & Machine Learning, Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Relocation Assistance
Company Equity
Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.
Ambry Genetics acquisition could pose financial risks if synergies aren't realized.
Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.
Their platform aids in personalized treatment decisions for cancer patients.
Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.
Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.
Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI